Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma

NCT04314245 is registered in ClinicalTrials.gov with AnchorDx Medical Co., Ltd. as lead sponsor.

NCT NCT04314245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04314245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma
Lead sponsor
AnchorDx Medical Co., Ltd.
Phase
Observational
Overall status
Completed
Start date
August 1, 2019
Completion date
August 31, 2022
Enrollment
1,170 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, urothelial carcinoma